June 6, 2022
Average monthly enrollment nearly doubled with pharmacy intervention Remote pharmacist easily adapted into clinic workflows in community practices THE WOODLANDS, TEXAS, June 6, 2022 — Results from the second phase of the broad, collaborative MYLUNG ConsortiumTM research study in non-small cell lung cancer (NSCLC) were presented by The US Oncology Network (The Network), US Oncology […]
Read MoreJune 3, 2022
Key research highlights include presentations on lung and ovarian cancers, value-based care, health technologies and health disparities THE WOODLANDS, Texas, June 3, 2022 — During the scientific program of the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, principal investigators from US Oncology Research, The US Oncology Network (The Network) and Ontada® will present detailed results from […]
Read MoreFebruary 8, 2022
Seven custom measures receive approval, raising the bar on oncology patient care IRVING, Texas, Feb. 8, 2022 — For the sixth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR). The designation enables iKnowMed℠ electronic health […]
Read MoreDecember 9, 2021
Highlights include clinical, real-world and health economic findings from studies of blood cancer treatments and hematological side effects in the community oncology setting THE WOODLANDS, Texas, Dec. 9, 2021 — Investigators from US Oncology Research, The US Oncology Network (The Network), and OntadaTM will share results from more than 30 studies exploring areas such as […]
Read MoreNovember 16, 2021
Practices using Oncology Care Model improved patient care while saving Medicare $197 million THE WOODLANDS, TEXAS, Nov. 16, 2021 — The Centers for Medicare & Medicaid Innovation (CMMI) recently released results for the 8th Performance Period (PP8) of the Oncology Care Model (OCM), and practices in The US Oncology Network (The Network) participating in the program […]
Read MoreSeptember 20, 2021
Successor will continue The Network’s success in supporting independent oncology practices nationwide THE WOODLANDS, TEXAS, Sept. 20, 2021 — The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that it has appointed Jason Hammonds as its new president. Hammonds has […]
Read MoreJune 4, 2021
Over 80 percent of non-small cell lung cancer detected at Stage 4 Fewer than 50 percent of patients had five or more biomarker tests Median time from diagnosis to first-line therapy is about five weeks THE WOODLANDS, TEXAS, June 4, 2021 — Results from the first phase of the broad, collaborative MYLUNG ConsortiumTM research study […]
Read MoreJune 3, 2021
Key highlights include a plenary session on cervical cancer among women in developing nations and an oral abstract exploring molecular testing and targeted therapy for metastatic non-small cell lung cancer, among other topics THE WOODLANDS, Texas, June 3, 2021 — US Oncology Research, The US Oncology Network (The Network), and OntadaTM announce they contributed to […]
Read MoreApril 1, 2021
By joining The Network, these physicians contribute to the expansion of colorectal services in Texas THE WOODLANDS, Texas, April 1, 2021—The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, continues to expand its reach into local communities while broadening its surgical expertise […]
Read MoreMarch 25, 2021
Eight custom measures receive approval, raising the bar on oncology patient care IRVING, Texas, March 25, 2021 — For the fifth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR). As a CMS-approved QCDR, Practice Insights, a […]
Read More
